Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies

α-Synuclein misfolding and aggregation is a hallmark in Parkinson's disease and in several other neurodegenerative diseases known as synucleinopathies. The toxic properties of α-synuclein are conserved from yeast to man, but the precise underpinnings of the cellular pathologies associated are still elusive, complicating the development of effective therapeutic strategies. Combining molecular genetics with target-based approaches, we established that glycation, an unavoidable age-associated post-translational modification, enhanced α-synuclein toxicity in vitro and in vivo, in Drosophila and in mice. Glycation affected primarily the N-terminal region of α-synuclein, reducing membrane binding, impaired the clearance of α-synuclein, and promoted the accumulation of toxic oligomers that impaired neuronal synaptic transmission. Strikingly, using glycation inhibitors, we demonstrated that normal clearance of α-synuclein was re-established, aggregation was reduced, and motor phenotypes in Drosophila were alleviated. Altogether, our study demonstrates glycation constitutes a novel drug target that can be explored in synucleinopathies as well as in other neurodegenerative conditions.

Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies

Hilal Lashuel, Abid Oueslati

A better understanding of the molecular and cellular determinants that influence the pathology of Parkinson's disease (PD) is essential for developing effective diagnostic, preventative and therapeutic strategies to treat this devastating disease. A number of post-translational modifications to alpha-syn are present within the Lewy bodies in the brains of affected patients and transgenic models of PD and related disorders. However, whether disease-associated alpha-syn post-translational modifications promote or inhibit alpha-syn aggregation and neurotoxicity in vivo remains unknown. Herein, we summarize and discuss the major disease-associated post-translational modifications (phosphorylation, truncation and ubiquitination) and present our current understanding of the effect of these modifications on alpha-syn aggregation and toxicity. Elucidating the molecular mechanisms underlying post-translation modifications of alpha-syn and the consequences of such modifications on the biochemical, structural, aggregation and toxic properties of the protein is essential for unravelling the molecular basis of its function(s) in health and disease. Furthermore, the identification of the natural enzymes involved in regulating the post-translational modifications of alpha-synuclein will yield novel and more tractable therapeutic targets to treat PD and related synucleinopathies.

Elsevier2010

New Insights Into Amyloid Formation and Structure by Innovative Atomic Force Microscopy Methods

Francesco Simone Ruggeri

Today, more than 40 million people worldwide are affected by neurodegenerative disorders. Onset of these diseases is associated with insoluble fibrillar protein aggregates, termed amyloids. The molecular origin and the link between amyloid formation and disease aetiology are unclear and there are not are available therapies for these disorders. Strong evidence links propensity of proteins to misfolding and aggregation to the pathological biology implicated in the onset of these diseases. Despite its importance, unraveling amyloids properties and formation is still a formidable experimental challenge, mainly because of their nanoscale dimensions and their heterogeneous and transient nature. Therefore, the investigation of the misfolding of monomers and oligomers into fibrils and their mechanical and structural properties is central to understand their stability and toxicity in the body and to design new therapeutic strategies to the amyloid diseases problem. The main objective of this PhD thesis was the biophysical investigation of amyloids structure and formation at the single scale aggregate. This objective was pursed mainly by the use of both conventional and innovative Atomic Force Microscopy (AFM) methodologies, such as peak force quantitative nanomechanical mapping (PF-QNM) and infrared nanospectroscopy (nanoIR). These methods were assessed to resolve the complex and heterogeneous energy landscape of proteins aggregation and to provide direct information on aggregates properties. Initially, we used AFM to compare the kinetics of aggregation of wild type and mutated forms of huntingtin and a-synuclein. In the first case, we focused on the effects of N-terminal post-translation modifications in the fibrillization. We demonstrated that a phosphorylation of the protein significantly slowed down the aggregation. In the latter case, we investigated wild type and H50Q mutated form of a-synuclein. We demonstrated the strict link between the disease and the mutation, which enhanced aggregation. Successively, we studied the early stages of a-synuclein fibrillization and we showed that the amyloid assembly proceed directly through the formation of single monomeric strands, which hierarchically assembly into the mature fibrils. Moreover, we performed force spectroscopy experiments, which confirmed the non-mature structure of this species and enabled studying their force of interaction with surfaces. Successively, PF-QNM was applied to investigate the mechanical properties of single aggregates forming during fibrillization of amyloid proteins. We demonstrated that Î²-sheet content is a major factor determining their intrinsic stiffness. Finally, nanoIR was applied to investigate at the nanoscale the misfolding process and the structure of the species present during the aggregation. The technique proved to be ideal to characterize individually the amyloid species formed by the Josephin domain of ataxin-3. For the first time, we were able to link their nanomechanical properties and secondary structure at the nanoscale. Innovative AFM-based techniques enabled correlating morphological and ultrastructural properties of amyloids at the single aggregate scale. Thus, they represent a future fruitful avenue to unravel protein misfolding process and the mechanisms of amyloid formation. The comprehension of these fundamental processes could allow the design of pharmacological approaches to contrast the onset of amyloid diseases.

EPFL2015

Exploring the role of post-translational modifications in regulating α-synuclein interactions by studying the effects of phosphorylation on nanobody binding

Anass Chiki, Farah El Turk, Bruno Claude Daniel Fauvet, Juan Kiwi, Hilal Lashuel

Intracellular deposits of α-synuclein in the form of Lewy bodies are major hallmarks of Parkinson’s disease (PD) and a range of related neurodegenerative disorders. Post-translational modifications (PTMs) of α-synuclein are increasingly thought to be major modulators of its structure, function, degradation and toxicity. Among these PTMs, phosphorylation near the C-terminus at S129 has emerged as a dominant pathogenic modification as it is consistently observed to occur within the brain and cerebrospinal fluid (CSF) of post-mortem PD patients, and its level appears to correlate with disease progression. Phosphorylation at the neighboring tyrosine residue Y125 has also been shown to protect against α-synuclein toxicity in a Drosophila model of PD. In the present study we address the potential roles of C-terminal phosphorylation in modulating the interaction of α-synuclein with other protein partners, using a single domain antibody fragment (NbSyn87) that binds to the C-terminal region of α-synuclein with nanomolar affinity. The results reveal that phosphorylation at S129 has negligible effect on the binding affinity of NbSyn87 to α-synuclein while phosphorylation at Y125, only four residues away, decreases the binding affinity by a factor of 400. These findings show that, despite the fact that α-synuclein is intrinsically disordered in solution, selective phosphorylation can modulate significantly its interactions with other molecules, and suggest how this particular form of modification could play a key role in regulating the normal and aberrant function of α-synuclein.

2018

New Insights Into Amyloid Formation and Structure by Innovative Atomic Force Microscopy Methods

Francesco Simone Ruggeri

EPFL2015